Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Tribble

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Oncotarget|October 6, 2025
ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Rα and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune responseKyle R Cron, Ping Fang, Oanh Pham, et al.
Nature Cell Biology|June 2, 2026
Nucleophagy removes cytotoxic trapped PARP1Gwendoline Hoslett, Sara Tribble, Pauline Lascaux, et al.
Cell|September 12, 2024
TEX264 drives selective autophagy of DNA lesions to promote DNA repair and cell survivalPauline Lascaux, Gwendoline Hoslett, Sara Tribble, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Oncotarget|October 6, 2025
ACTM-838, a novel systemically delivered bacterial immunotherapy that enriches in solid tumors and delivers IL-15/IL-15Rα and STING payloads to engage innate and adaptive immunity in the TME and enable a durable anti-tumor immune responseKyle R Cron, Ping Fang, Oanh Pham, et al.
Nature Cell Biology|June 2, 2026
Nucleophagy removes cytotoxic trapped PARP1Gwendoline Hoslett, Sara Tribble, Pauline Lascaux, et al.
Cell|September 12, 2024
TEX264 drives selective autophagy of DNA lesions to promote DNA repair and cell survivalPauline Lascaux, Gwendoline Hoslett, Sara Tribble, et al.
Pageof 1